NMR and Thermal Studies for the Characterization of Mass Transport and Phase Separation in Paracetamol/Copovidone Hot-Melt Extrusion Formulations.

API−polymer interaction Arrhenius model PFG NMR Stokes−Einstein equation amorphous solid dispersion diffusion hot-melt extrusion

Journal

Molecular pharmaceutics
ISSN: 1543-8392
Titre abrégé: Mol Pharm
Pays: United States
ID NLM: 101197791

Informations de publication

Date de publication:
01 06 2020
Historique:
pubmed: 17 4 2020
medline: 8 6 2021
entrez: 17 4 2020
Statut: ppublish

Résumé

The formulation of drug/polymer amorphous solid dispersions (ASDs) is one of the most successful strategies for improving the oral bioavailability of poorly soluble active pharmaceutical ingredients (APIs). Hot-melt extrusion (HME) is one method for preparing ASDs that is growing in importance in the pharmaceutical industry, but there are still substantial gaps in our understanding regarding the dynamics of drug dissolution and dispersion in viscous polymers and the physical stability of the final formulations. Furthermore, computational models have been built to predict optimal processing conditions, but they are limited by the lack of experimental data for key mass transport parameters, such as the diffusion coefficient. The work presented here reports direct measurements of API diffusion in pharmaceutical polymer melts, using high-temperature pulsed-field gradient NMR. The diffusion coefficient of a model drug/polymer system (paracetamol/copovidone) was determined for different drug loadings and at temperatures relevant to the HME process. The mechanisms of the diffusion process are also explored with the Stokes-Einstein and Arrhenius models. The results show that diffusivity is linked exponentially to temperature. Furthermore, this study includes rheological characterization, differential scanning calorimetry (DSC), and

Identifiants

pubmed: 32298130
doi: 10.1021/acs.molpharmaceut.0c00188
doi:

Substances chimiques

Polymers 0
Pyrrolidines 0
Vinyl Compounds 0
poly(vinylpyrrolidone-co-vinyl-acetate) 0
Acetaminophen 362O9ITL9D

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2021-2033

Auteurs

Elena Pisa (E)

Department of Chemical Engineering and Biotechnology, University of Cambridge, Philippa Fawcett Drive, Cambridge CB3 0AS, U.K.

Leslie P Hughes (LP)

Global Product Development, AstraZeneca, Charter Way, Macclesfield SK10 2NA, U.K.

Stephen A C Wren (SAC)

Global Product Development, AstraZeneca, Charter Way, Macclesfield SK10 2NA, U.K.

Jonathan Booth (J)

Global Product Development, AstraZeneca, Charter Way, Macclesfield SK10 2NA, U.K.

James Francis McCabe (JF)

Pharmaceutical Development, AstraZeneca, Charter Way, Macclesfield SK10 2NA, U.K.

David T E Whittaker (DTE)

Early Chemical Development, Pharmaceutical Sciences, R&D, AstraZeneca, Macclesfield SK10 2NA, U.K.

Mick D Mantle (MD)

Department of Chemical Engineering and Biotechnology, University of Cambridge, Philippa Fawcett Drive, Cambridge CB3 0AS, U.K.

Articles similaires

Semiconductors Photosynthesis Polymers Carbon Dioxide Bacteria
Fucosyltransferases Drug Repositioning Molecular Docking Simulation Molecular Dynamics Simulation Humans
Animals Huntington Disease Mitochondria Neurons Mice
Nitriles Tensile Strength Materials Testing Gloves, Protective Product Packaging

Classifications MeSH